Literature DB >> 35951036

[Is elective irradiation of lymph node levels IV and Vb necessary in nasopharyngeal carcinoma?]

Sabine Semrau1, Marlen Haderlein2.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35951036      PMCID： PMC9581874          DOI： 10.1007/s00066-022-01986-3

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   4.033


× No keyword cloud information.
  6 in total

1.  The volume to be irradiated during selective neck irradiation in nasopharyngeal carcinoma: analysis of the spread patterns in lymph nodes by magnetic resonance imaging.

Authors:  Linglong Tang; Yanping Mao; Lizhi Liu; Shaobo Liang; Yong Chen; Ying Sun; Xinbiao Liao; Aihua Lin; Mengzhong Liu; Li Li; Jun Ma
Journal:  Cancer       Date:  2009-02-01       Impact factor: 6.860

2.  Treatment outcomes and feasibility of partial neck irradiation for patients with nasopharyngeal carcinoma with only retropharyngeal lymph node metastasis after intensity-modulated radiotherapy.

Authors:  Mo Chen; Ling-Long Tang; Ying Sun; Yan-Ping Mao; Wen-Fei Li; Rui Guo; Li-Zhi Liu; Li Li; Ai-Hua Lin; Jun Ma
Journal:  Head Neck       Date:  2013-06-18       Impact factor: 3.147

3.  Elective upper-neck versus whole-neck irradiation of the uninvolved neck in patients with nasopharyngeal carcinoma: an open-label, non-inferiority, multicentre, randomised phase 3 trial.

Authors:  Ling-Long Tang; Cheng-Long Huang; Ning Zhang; Wei Jiang; Yi-Shan Wu; Shao Hui Huang; Yan-Ping Mao; Qing Liu; Ji-Bin Li; Shao-Qiang Liang; Guan-Jie Qin; Wei-Han Hu; Ying Sun; Fang-Yun Xie; Lei Chen; Guan-Qun Zhou; Jun Ma
Journal:  Lancet Oncol       Date:  2022-02-28       Impact factor: 41.316

4.  Dose-dependent deterioration of swallowing function after induction chemotherapy and definitive chemoradiotherapy for laryngopharyngeal cancer.

Authors:  M Haderlein; S Semrau; O Ott; S Speer; C Bohr; R Fietkau
Journal:  Strahlenther Onkol       Date:  2014-02       Impact factor: 3.621

5.  Distant metastasis risk and patterns of nasopharyngeal carcinoma in the era of IMRT: long-term results and benefits of chemotherapy.

Authors:  An-Chuan Li; Wei-Wei Xiao; Guan-Zhu Shen; Lin Wang; An-An Xu; Yan-Qing Cao; Shao-Min Huang; Cheng-Guang Lin; Fei Han; Xiao-Wu Deng; Chong Zhao
Journal:  Oncotarget       Date:  2015-09-15

6.  International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma.

Authors:  Anne W Lee; Wai Tong Ng; Jian Ji Pan; Sharon S Poh; Yong Chan Ahn; Hussain AlHussain; June Corry; Cai Grau; Vincent Grégoire; Kevin J Harrington; Chao Su Hu; Dora L Kwong; Johannes A Langendijk; Quynh Thu Le; Nancy Y Lee; Jin Ching Lin; Tai Xiang Lu; William M Mendenhall; Brian O'Sullivan; Enis Ozyar; Lester J Peters; David I Rosenthal; Yoke Lim Soong; Yungan Tao; Sue S Yom; Joseph T Wee
Journal:  Radiother Oncol       Date:  2017-11-15       Impact factor: 6.280
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.